These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 2833974

  • 1. Safety of surveillance in the management of stage I anaplastic germ cell tumours of the testis.
    Crawford SM, Rustin GJ, Begent RH, Newlands ES, Bagshawe KD.
    Br J Urol; 1988 Mar; 61(3):250-3. PubMed ID: 2833974
    [Abstract] [Full Text] [Related]

  • 2. [CCAFU Recommendations 2013: Testicular germ cell cancer].
    Durand X, Rigaud J, Avancès C, Camparo P, Fléchon A, Murez T, Sèbe P, Culine S, Iborra F, Mottet N, Coloby P, Soulié M, Les membres du CCAFU.
    Prog Urol; 2013 Nov; 23 Suppl 2():S145-60. PubMed ID: 24485289
    [Abstract] [Full Text] [Related]

  • 3. [CCAFU french national guidelines 2016-2018 on testicular germ cell tumors].
    Durand X, Fléchon A, Murez T, Rocher L, Camparo P, Morel-Journel N, Savoie PH, Ferretti L, Sèbe P, Méjean A.
    Prog Urol; 2016 Nov; 27 Suppl 1():S147-S165. PubMed ID: 27846929
    [Abstract] [Full Text] [Related]

  • 4. Testicular carcinoma.
    O'Callaghan A, Mead GM.
    Postgrad Med J; 1997 Aug; 73(862):481-6. PubMed ID: 9307739
    [Abstract] [Full Text] [Related]

  • 5. [The role of tumour markers in diagnosis and management of testicular germ cell tumours].
    Krege S, Albers P, Heidenreich A.
    Urologe A; 2011 Mar; 50(3):313-21. PubMed ID: 21327901
    [Abstract] [Full Text] [Related]

  • 6. Testicular cancer. Clinical practice guidelines in oncology.
    Motzer RJ, Bolger GB, Boston B, Carducci MA, Fishman M, Hancock SL, Hauke RJ, Hudes GR, Jonasch E, Kantoff P, Kuzel TM, Lange PH, Levine EG, Logothetis C, Margolin KA, Pohar KS, Redman BG, Robertson CN, Samlowski WE, Sheinfeld J, National Comprehensive Cancer Network.
    J Natl Compr Canc Netw; 2006 Nov; 4(10):1038-58. PubMed ID: 17112452
    [No Abstract] [Full Text] [Related]

  • 7. Imaging of testicular germ cell tumours.
    Dalal PU, Sohaib SA, Huddart R.
    Cancer Imaging; 2006 Sep 07; 6(1):124-34. PubMed ID: 16966068
    [Abstract] [Full Text] [Related]

  • 8. Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review.
    Chakiryan NH, Dahmen A, Cucchiara V, Briganti A, Montorsi F, Salonia A, Spiess PE, Necchi A.
    J Urol; 2021 Jun 07; 205(6):1569-1576. PubMed ID: 33617328
    [Abstract] [Full Text] [Related]

  • 9. MicroRNAs as Biomarkers for Germ Cell Tumors.
    Nappi L, Nichols C.
    Urol Clin North Am; 2019 Aug 07; 46(3):449-457. PubMed ID: 31277739
    [Abstract] [Full Text] [Related]

  • 10. Surveillance in testicular cancer: who, when, what and how?
    Sohaib SA, Husband J.
    Cancer Imaging; 2007 Oct 22; 7(1):145-7. PubMed ID: 17964956
    [Abstract] [Full Text] [Related]

  • 11. [Diagnostic parameters and their value in testicular tumors].
    Bürgler W, Jaeger P.
    Urologe A; 1986 May 22; 25(3):157-9. PubMed ID: 3016965
    [Abstract] [Full Text] [Related]

  • 12. [Clinical presentation of testicular germinal cancer].
    Fernández Gómez JM, Guate Ortiz JL, Martín Huescar A, Fresno Forcelledo F, Escaf Barmadah S, García Rodríguez J, Pérez García FJ, Rodríguez Faba O, Jalón Monzón A.
    Arch Esp Urol; 2002 Oct 22; 55(8):915-22. PubMed ID: 12455282
    [Abstract] [Full Text] [Related]

  • 13. [Testicular germ-cell tumour: diagnosis and treatment].
    Houlgatte A, Bauduceau O.
    Ann Urol (Paris); 2005 Oct 22; 39(5):159-69. PubMed ID: 16370168
    [Abstract] [Full Text] [Related]

  • 14. Active surveillance for stage I non-seminomatous germ cell testis tumors: practice and pitfalls.
    Raghavan D, Boyer M.
    Prog Clin Biol Res; 1990 Oct 22; 350():309-18. PubMed ID: 2166960
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic factors in metastatic disease.
    Droz JP, Kramar A, Rey A.
    Semin Oncol; 1992 Apr 22; 19(2):181-9. PubMed ID: 1372760
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Early detection of relapse after treatment for metastatic germ cell tumour of the testis: an exercise in medical audit.
    Rathmell AJ, Brand IR, Carey BM, Jones WG.
    Clin Oncol (R Coll Radiol); 1993 Apr 22; 5(1):34-8. PubMed ID: 7678749
    [Abstract] [Full Text] [Related]

  • 18. Clinical examination does not assist in the detection of systemic relapse of testicular germ cell tumour.
    Cunniffe NG, Robson J, Mazhar D, Williams MV.
    Clin Oncol (R Coll Radiol); 2012 Feb 22; 24(1):39-42. PubMed ID: 21723715
    [Abstract] [Full Text] [Related]

  • 19. Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center.
    Nicolai N, Tarabelloni N, Gasperoni F, Catanzaro M, Stagni S, Torelli T, Tesone A, Bettin L, Necchi A, Giannatempo P, Raggi D, Colecchia M, Piva L, Salvioni R, Paganoni AM, Pizzocaro G, Biasoni D.
    J Urol; 2018 Mar 22; 199(3):741-747. PubMed ID: 28964782
    [Abstract] [Full Text] [Related]

  • 20. Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series.
    Anheuser P, Radtke A, Wülfing C, Kranz J, Belge G, Dieckmann KP.
    Urol Int; 2017 Mar 22; 99(1):98-103. PubMed ID: 28586780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.